The consumption of sugar-sweetened beverages is driving millions of diabetes and heart disease cases worldwide, with significant regional health inequalities.
Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement | Psychedelic Invest
Psyence Group Inc. (CSE:PSYG / OTCQB: PSYGF), a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being (“Psyence”),